I am an Associate Professor of Pathology at UAB, and was surprised when, shortly after moving to the Birmingham are in 2013, I was diagnosed with leukemia. As a researcher of diabetes and cardiovascular diseases, I had no idea how many advances had been made in the world of oncology. However, owing to the discovery of tyrosine kinase inhibitors, like Gleevec and Sprycel, and the outstanding medical care I received at the O’Neal Comprehensive Cancer Center and Kirklin Clinics, I was quickly cured. However, not all have been so lucky, and that is why I have now put my love of running to help put an end to blood cancer for others.
After a close friend died of a different form of leukemia in November if 2018, I joined Team in Training to help raise funds for the Leukemia and Lymphoma Society (LLS). LLS is a non-profit organization that helps fund ground-breaking blood cancer research, provide co-pay assistance for patients, and other support for families. Since 1949 LLS has invested over $1.3 billion dollars in research that has led to life-saving advancements in immunotherapy, genomics, and personalized medicine. They have supported over $6 million in research at UAB alone. As I started to wean off Sprycel this month, I realize that there is more to be done for patients like me and those who were not able to make it this far.
My goal for 2020 is to raise over $20,000 for LLS. This will culminate, on April 26th 2020, when I will be running with Team in Training in the London Marathon.
As I strive for this goal, I need help from people like you!
Please consider helping this cause (even for a year-end tax-deductible donation) at the website here: https://pages.lls.org/tnt/al/london20/awende. There, you can find a secure way to donate, plus much more information about this journey and decision to take on this challenge.
Any amount is appreciated and if a donation is not in your plans, please share/forward my story to anyone who has been touched by cancer and might be interested in helping contribute to ending cancer for others, just like I beat my cancer, it will be much appreciated.
Adam R. Wende, PhD, FAHA is an Associate Professor in the Department of Molecular and Cellular Pathology in the School of Medicine at the University of Alabama at Birmingham
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: